◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › EYPT

EyePoint, Inc. (EYPT) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

EyePoint, Inc. (EYPT) operates in the Biotechnology industry and is headquartered in Watertown, United States with about 214 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, EYPT reported $31M in revenue and ($232M) in net income.

EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery.

Interactive charts & full statements → Open the EYPT valuation workbench →

EYPT Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$31M$43M$46M$41M
Gross Profit$29M$40M$41M$33M
Operating Income (EBIT)($243M)($146M)($75M)($79M)
Net Income($232M)($131M)($71M)($102M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EYPT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$1M$1M$1M$5M$24M
Gross Profit$0M$0M$0M$5M$24M
Operating Income (EBIT)($87M)($70M)($62M)($62M)($49M)
Net Income($85M)($68M)($60M)($59M)($45M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EYPT Free Cash Flow History

EYPT Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$364M$418M$355M$180M
Total Liabilities$58M$82M$89M$84M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EYPT viewer.

Other Companies in Biotechnology

← EYEAll stocksEZGO →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.